Clinical trial
Combination Chemotherapy With or Without Rituximab in Treating Older Patients…
NCT00052936 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Completed
Key facts
| NCT number | NCT00052936 |
|---|---|
| Title | Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma |
| Official title | Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Years With Aggressive Non-Hodgkin's Lymphoma |
| Lead sponsor | German High-Grade Non-Hodgkin's Lymphoma Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, rituximab, CHOP regimen, cyclophosphamide, doxorubicin hydrochloride, prednisone, vincristine sulfate, radiation therapy |
| Enrollment | 1,506 |
| Start date | Jan 1, 2001 |
| Primary completion | Aug 5, 2010 |
| Completion | Aug 5, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | May 18, 2021 |
| Countries | Germany, Switzerland |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: